Viatris (VTRS): are the analysts right?

Viatris · Health Care · ref. ETF XLV · 47 calls · price $16.96
What the company does: Viatris Inc. est une société de soins de santé pharmaceutiques opérant en Amérique du Nord, Europe, Asie et autres régions.
📈 1-year price
$16.96+83.2% over range
Jul 8, 25low $8.74 · high $17.39Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
60% recommend buying · 5 analysts

🎯 Analyst price target on VTRS

High target · 1 analyst$22+29.7%
Median target · 5 analysts$18+6.1%
Low target · 1 analyst$12-29.2%
Current price$16.96

🗳️ The analyst consensus

Analyst breakdown · 5 (6 months)
Strong Buy0%
Buy60%
Hold40%
Sell0%
Strong Sell0%

💰 Viatris dividend

2.97%annual yield
That's ~$0.48 per share per year.

✅ Historical analyst reliability on VTRS

Most reliable analysts on VTRS (% profitable · 365j · ≥2 calls)
Jefferies 50% +24.8% 2
Barclays 33% -9.5% 6
Raymond James 0% -10.4% 2
B of A Securities 0% -50.5% 2

📊 What $1,000 invested in Viatris would be worth

In short — $1,000 invested in Viatris 10 years ago would be worth $352 today, i.e. -10%/yr on average. Best year: 2025 (+62%), worst: 2019 (-35%). Price performance, excluding dividends.

If I'd invested $1,000 in Viatris

InvestmentWorth todayGain
1 years ago$1,720+72%
3 years ago$1,393+39%
5 years ago$1,069+7%
10 years ago$352-65%
since inception (1984)$5,955+495%

Return by year (Viatris)

YearReturn$1,000 invested at year start
2026 (YTD)+6%$1,064 (+6%)
2025+62%$1,720 (+72%)
2024-25%$1,284 (+28%)
2023+9%$1,393 (+39%)
2022+4%$1,442 (+44%)
2021-26%$1,069 (+7%)
2020-14%$924 (-8%)
2019-35%$602 (-40%)
2018-35%$394 (-61%)
2017-4%$379 (-62%)
2016-7%$352 (-65%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on VTRS

Barclays
May 19, 26
▲ Overweight · 🎯$22
Price at call : $16.17 — upside +36%
Today : $16.96 — upside +30%
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 19, 27
JP Morgan
May 8, 26
■ Neutral neutral · not a buy · 🎯$18
Price at call : $16.92 — gap to target +6%
Today : $16.96 — gap to target +6%
🎯 on VTRS : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : May 8, 27
▲ Buy · 🎯$20
Price at call : $16.92 — upside +18%
Today : $16.96 — upside +18%
🎯 on VTRS : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : May 8, 27
Barclays
Mar 24, 26
▲ Overweight · 🎯$17
Price at call : $13.5 — upside +26%
Today : $16.96 — upside +0%
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Mar 24, 27
Piper Sandler
Jan 28, 26
■ Neutral neutral · not a buy · 🎯$12
Price at call : $12.97 — gap to target -7%
Today : $16.96 — gap to target -29%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jan 28, 27
▲ Buy · 🎯$15
Price at call : $12.86 — upside +17%
Today : $16.96 — upside -12%
🎯 on VTRS : no call matured yet · 📊 on Health : 56.4% · +2.9% (156 calls)
in progress (365j)
matures : Jan 16, 27
Barclays
Dec 9, 25
▲ Overweight · 🎯$15
Price at call : $11.6 — upside +29%
Today : $16.96 — upside -12%
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Dec 9, 26
▲ Buy · 🎯$15
Price at call : $9.98 — upside +50%
Today : $16.96 — upside -12%
🎯 on VTRS : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Oct 15, 26
■ Neutral neutral · not a buy · 🎯$10
Price at call : $8.81 — gap to target +14%
Today : $16.96 — gap to target -41%
🎯 on VTRS : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Jun 6, 26
Jefferies
Mar 7, 25
▲ Buy · 🎯$13
Price at call : $9.5 — upside +37%
Today : $16.96 — upside -23%
Expected +37% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on VTRS : 50% (2 calls matureds) · 📊 on Health : 50.5% · +4.5% (376 calls)
+49.7%
stock +50% · XLV +4%
■ Neutral neutral · not a buy · 🎯$10
Price at call : $9.51 — gap to target +5%
Today : $16.96 — gap to target -41%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Mar 5, 26
Barclays
Feb 28, 25
▼ Underweight · 🎯$9
Price at call : $9.33 — upside -4%
Today : $16.96 — upside -47%
Expected -4% · Actual +68% · Reason (≤ −15%) : ✗ No
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-68.3%
stock +68% · XLV +6%
▼ Underperform · 🎯$10
Price at call : $9.23 — upside +8%
Today : $16.96 — upside -41%
Expected +8% · Actual +70% · Reason (≤ −15%) : ✗ No
🎯 on VTRS : 0% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
-70.1%
stock +70% · XLV +6%
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.72 — gap to target +10%
Today : $16.96 — gap to target -17%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Dec 6, 25
Barclays
Nov 8, 24
▼ Underweight · 🎯$12
Price at call : $13.09 — upside -8%
Today : $16.96 — upside -29%
Expected -8% · Actual -22% · Reason (≤ −15%) : ✓ Yes
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+22.3%
stock -22% · XLV -1%
Piper Sandler
Mar 28, 24
■ Neutral neutral · not a buy · 🎯$13
Price at call : $11.94 — gap to target +9%
Today : $16.96 — gap to target -23%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Mar 28, 25
Piper Sandler
Nov 22, 23
■ Neutral neutral · not a buy · 🎯$11
Price at call : $9.43 — gap to target +17%
Today : $16.96 — gap to target -35%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 21, 24
▼ Underperform · 🎯$9
Price at call : $8.92 — upside +1%
Today : $16.96 — upside -47%
Expected +1% · Actual +31% · Reason (≤ −15%) : ✗ No
🎯 on VTRS : 0% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
-30.8%
stock +31% · XLV +19%
Barclays
Jun 23, 23
▼ Underweight · 🎯$11
Price at call : $9.76 — upside +13%
Today : $16.96 — upside -35%
Expected +13% · Actual +7% · Reason (≤ −15%) : ✗ No
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-7.3%
stock +7% · XLV +11%
Barclays
Apr 25, 23
■ Equal-Weight neutral · not a buy · 🎯$11
Price at call : $9.18 — gap to target +20%
Today : $16.96 — gap to target -35%
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Apr 24, 24
Barclays
Apr 24, 23
■ Equal-Weight neutral · not a buy · 🎯$11
Price at call : $9.33 — gap to target +18%
Today : $16.96 — gap to target -35%
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Apr 23, 24
Barclays
Feb 28, 23
▲ Overweight · 🎯$16
Price at call : $11.4 — upside +40%
Today : $16.96 — upside -6%
Expected +40% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+7.8%
stock +8% · XLV +15%
BMO Capital
Feb 17, 23
■ Market Perform neutral · not a buy · 🎯$14
Price at call : $11.69 — gap to target +20%
Today : $16.96 — gap to target -17%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Feb 17, 24
Barclays
Feb 1, 23
▲ Overweight · 🎯$15
Price at call : $12.26 — upside +22%
Today : $16.96 — upside -12%
Expected +22% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-3.2%
stock -3% · XLV +6%
Jefferies
Jan 27, 23
▲ Buy · 🎯$15
Price at call : $11.89 — upside +26%
Today : $16.96 — upside -12%
Expected +26% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on VTRS : 50% (2 calls matureds) · 📊 on Health : 50.5% · +4.5% (376 calls)
-0.1%
stock -0% · XLV +6%
JP Morgan
Nov 15, 22
■ Neutral neutral · not a buy · 🎯$14
Price at call : $11.08 — gap to target +26%
Today : $16.96 — gap to target -17%
🎯 on VTRS : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Nov 15, 23
UBS
Nov 10, 22
■ Neutral neutral · not a buy · 🎯$12
Price at call : $11.34 — gap to target +6%
Today : $16.96 — gap to target -29%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 10, 23
■ Neutral neutral · not a buy · 🎯$10
Price at call : $11.1 — gap to target -10%
Today : $16.96 — gap to target -41%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 8, 23
Barclays
Oct 25, 22
▲ Overweight · 🎯$16
Price at call : $9.78 — upside +64%
Today : $16.96 — upside -6%
Expected +64% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on VTRS : 33% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-8.3%
stock -8% · XLV -3%
Jefferies
Oct 21, 22
■ Hold neutral · not a buy · 🎯$11
Price at call : $9.38 — gap to target +17%
Today : $16.96 — gap to target -35%
🎯 on VTRS : 50% (2 calls matureds) · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Oct 21, 23
BMO Capital
Aug 9, 22
▲ Outperform · 🎯$16
Price at call : $10.46 — upside +53%
Today : $16.96 — upside -6%
Expected +53% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 60.9% · +9.2% (235 calls)
+7.6%
stock +8% · XLV +3%
UBS
Jun 14, 22
▼ Sell · 🎯$9
Price at call : $10.7 — upside -16%
Today : $16.96 — upside -47%
Expected -16% · Actual -7% · Reason (≤ −15%) : ✗ No
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
+7.1%
stock -7% · XLV +9%
Goldman Sachs
May 12, 22
■ Neutral neutral · not a buy · 🎯$11
Price at call : $11.08 — gap to target -1%
Today : $16.96 — gap to target -35%
🎯 on VTRS : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : May 12, 23
Piper Sandler
May 10, 22
▼ Underweight · 🎯$10
Price at call : $10.46 — upside -4%
Today : $16.96 — upside -41%
Expected -4% · Actual -8% · Reason (≤ −15%) : ✗ No
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
+8.3%
stock -8% · XLV +5%
Piper Sandler
Mar 16, 22
■ Neutral neutral · not a buy · 🎯$10
Price at call : $10.64 — gap to target -6%
Today : $16.96 — gap to target -41%
🎯 on VTRS : 100% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Mar 16, 23
Citigroup
Mar 10, 22
■ Neutral neutral · not a buy · 🎯$11
Price at call : $10.12 — gap to target +9%
Today : $16.96 — gap to target -35%
🎯 on VTRS : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 10, 23
■ Neutral neutral · not a buy · 🎯$13
Price at call : $10.15 — gap to target +28%
Today : $16.96 — gap to target -23%
🎯 on VTRS : 0% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Mar 1, 23
■ Market Perform neutral · not a buy
🎯 on VTRS : 0% (2 calls matureds) · 📊 on Health : 46.8% · +2.0% (395 calls)
in progress (365j)
matures : Mar 1, 23
Citigroup
Jun 15, 21
■ Neutral neutral · not a buy · 🎯$16
Price at call : $15.3 — gap to target +5%
Today : $16.96 — gap to target -6%
🎯 on VTRS : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jun 15, 22
■ Equal-Weight neutral · not a buy · 🎯$16
Price at call : $14.1 — gap to target +13%
Today : $16.96 — gap to target -6%
🎯 on VTRS : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Mar 10, 22
■ Neutral neutral · not a buy · 🎯$15
Price at call : $13.83 — gap to target +8%
Today : $16.96 — gap to target -12%
🎯 on VTRS : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Mar 8, 22
JP Morgan
Mar 2, 21
■ Neutral neutral · not a buy · 🎯$18
Price at call : $14.29 — gap to target +26%
Today : $16.96 — gap to target +6%
🎯 on VTRS : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Mar 2, 22
Raymond James
Feb 23, 21
▲ Outperform · 🎯$19
Price at call : $15.22 — upside +25%
Today : $16.96 — upside +12%
Expected +25% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on VTRS : 0% (2 calls matureds) · 📊 on Health : 46.8% · +2.0% (395 calls)
-5.9%
stock -6% · XLV +11%
Raymond James
Jan 25, 21
▲ Outperform · 🎯$23
Price at call : $17.23 — upside +33%
Today : $16.96 — upside +36%
Expected +33% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on VTRS : 0% (2 calls matureds) · 📊 on Health : 46.8% · +2.0% (395 calls)
-14.8%
stock -15% · XLV +8%
■ Hold neutral · not a buy
🎯 on VTRS : no call matured yet · 📊 on Health : 56.4% · +2.9% (156 calls)
in progress (365j)
matures : Jan 5, 22
Bernstein
Dec 14, 20
■ Market Perform neutral · not a buy · 🎯$21
Price at call : $17.73 — gap to target +18%
Today : $16.96 — gap to target +24%
🎯 on VTRS : no call matured yet · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : Dec 14, 21
Edward Jones
Nov 18, 20
▼ Sell
Actual -17% · Reason (≤ −15%) : ✓ Yes
🎯 on VTRS : 100% (1 call matured) · 📊 unranked overall
+17.3%
stock -17% · XLV +23%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)